Optiscan device selected for prestigious trial
Medical equipment manufacturer Optiscan Imaging (ASX: OIL) has announced its virtual biopsy technology has been selected for a cancer trial at the prestigious Memorial Sloan Kettering Cancer Centre in New York. The Centre will use the Optiscan system and confocal laser endomicroscope technology for an oral cancer human clinical trial to begin shortly. Optiscan views…